BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27060321)

  • 1. [Karyotype analysis and fluorescence in situ hybridization detection of 122 patients with myelodysplastic syndrome].
    Jing Y; Lin S; Jiang F; Wang F; Fang M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Apr; 33(2):221-6. PubMed ID: 27060321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study of fluorescence in situ hybridization versus conventional cytogenetics in the detection of clonal aberrations in myelodysplastic syndrome].
    Lai YY; Li N; Feng L; Shi Y; Dang H; He Q; Wang Z; Wang XY; Li Y; Liu Q; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3175-9. PubMed ID: 24405535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytogenetic abnormalities of 50 MDS patients by FISH detection and conventional karyotype analysis].
    Gao DG; Li BT; Zhou LN; Chen H; Zhang B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1190-4. PubMed ID: 24156432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detecting chromosomal aberrations in myelodysplastic syndrome with fluorescence in situ hybridization and conventional cytogenetic analysis].
    Cao P; Li Y; Li X; Zhang G; Chen F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 39(6):605-11. PubMed ID: 25011965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study.
    Pitchford CW; Hettinga AC; Reichard KK
    Am J Clin Pathol; 2010 Feb; 133(2):260-4. PubMed ID: 20093235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of common chromosome abnormalities in myelodysplastic syndrome with a panel fluorescence in situ hybridization].
    Shen Y; Xue Y; Li J; Pan J; Wu Y; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):160-3. PubMed ID: 12673589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of cytogenetic abnormalities involving chromosomes 5,7 and 8 in myelodysplastic syndromes with fluorescence in situ hybridization and its clinical significance].
    Cai Y; Qin YW; Wang C; Yang J; Yan SK
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):6-10. PubMed ID: 17649717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of I-FISH and G-banding for the detection of chromosomal abnormalities during the evolution of myelodysplastic syndrome.
    Pinheiro RF; Chauffaille ML
    Braz J Med Biol Res; 2009 Nov; 42(11):1110-2. PubMed ID: 19855907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [WHO classification and cytogenetic analysis of 435 cases with myelodysplastic syndrome].
    Wang XQ;
    Zhonghua Nei Ke Za Zhi; 2008 Jun; 47(6):464-7. PubMed ID: 19040061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failure.
    Jiang H; Xue Y; Wang Q; Pan J; Wu Y; Zhang J; Bai S; Wang Q; He G; Sun A; Wu D; Chen S
    Leuk Res; 2012 Apr; 36(4):448-52. PubMed ID: 22047706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of monosomy 7 or 7q- in cases of myelodysplastic syndrome].
    Shen Y; Xue Y; Li J; Guo Y; Pan J; Wu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):255-8. PubMed ID: 11484160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].
    Chen LJ; Li JY; Xiao B; Zhu Y; Liu Q; Pan JL; Qiu HR; Fan L; Zhang SJ; Lu RN; Xu W; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):635-9. PubMed ID: 18067073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of cytogenetic characteristics in patients with myelodysplastic syndrome].
    Ma L; Zhong MH; Han CW; Wang JY; Cao YT; Ma YG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1405-9. PubMed ID: 23257442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
    Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS;
    Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
    Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
    Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of complex karyotype in a myelodysplastic syndrome cell line (MUTZ-1) by metaphase fluorescence in situ hybridization.
    Chen BA; Xia GH; Li JY; Xiao B; Shao ZY; Chen NN; Gao C; Wu YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):46-9. PubMed ID: 16584590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiplex fluorescence in situ hybridization in detecting complex chromosomal aberrations in myelodysplastic syndromes].
    Xiao B; Li JY; Pan JL; Ma L; Qiu HR; Wu YF; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):513-6. PubMed ID: 16468325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FISH analysis in addition to G-band karyotyping: utility in evaluation of myelodysplastic syndromes?
    Yang W; Stotler B; Sevilla DW; Emmons FN; Murty VV; Alobeid B; Bhagat G
    Leuk Res; 2010 Apr; 34(4):420-5. PubMed ID: 19800120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of chromosome abnormalities in myelodysplastic syndromes with interval fluorescence in situ hybridization].
    Ru X; Li Q; Fang XS; Li Y; Wang X; Zhang LY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):116-20. PubMed ID: 23484703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.